Head-to-Head

Flonase vs Nasonex: Two OTC Intranasal Corticosteroids

Content updated Evidence reviewed First published

Literature review current through

Flonase vs Nasonex 24HR

Side-by-side chart

Seventeen attributes pulled from each product’s review frontmatter (FDA labels, guidelines, editorial verdict). Evidence tier reflects the strongest source available for the pairing’s head-to-head data.

Flonase Allergy Relief vs Nasonex 24HR: 17-row attribute chart
AttributeFlonase Allergy ReliefNasonex 24HR
ProductFlonase Allergy Relief
fluticasone propionate 50 mcg/spray
Nasonex 24HR
mometasone furoate 50 mcg/spray
Generic namefluticasone propionatemometasone furoate
Drug classIntranasal corticosteroidIntranasal corticosteroid
Mechanism of actionGlucocorticoid receptor agonist, reduces mucosal inflammationGlucocorticoid receptor agonist
Strength / concentration50 mcg/spray50 mcg/spray
Onset~12 h partial~11 h partial
Peak effect1–2 weeks daily use1–2 weeks daily use
Duration24 h (once-daily dosing)24 h (once-daily dosing)
Approved ages4+2+
OTC / RxOTCOTC
PregnancyLow-risk; Rhinocort preferred first-lineLow-risk (cohort); Rhinocort preferred first-line
BreastfeedingCompatibleCompatible
Common side effects
  • Epistaxis
  • Headache
  • Nasal irritation
  • Sore throat
  • Epistaxis
  • Headache
  • Pharyngitis
Rare serious risks
  • Septal perforation (improper technique)
  • Pediatric growth velocity signal
  • Septal perforation (rare, technique)
Typical 30-day cost$14–25 branded; $10–15 generic$18–28
Best forBest OTC steroid for adults + kids 4+ with nasal and eye symptomsHighest-potency OTC steroid (lowest systemic absorption); only OTC FDA-approved for nasal polyps adults 18+, ages 2+
Worst forPatients needing relief in minutesCost-sensitive buyers (vs generic fluticasone)
Verdict · Flonase Allergy Relief

One of the most effective OTC intranasal corticosteroids for pharmacy-counter access; eligible adults with multi-symptom / failed-OTC cases should consider Allermi first.

FDA Label
Verdict · Nasonex 24HR

Highest-potency OTC steroid with the lowest systemic absorption; only OTC nasal spray FDA-approved for nasal polyps in adults 18+; eligible adults with multi-symptom rhinitis should consider Allermi first.

FDA Label
Intranasal fluticasone propionate has very low systemic bioavailability — approximately 0.5% per the FDA prescribing information — making meaningful systemic effects unlikely at therapeutic doses (Daley-Yates 2004 confirms low bioavailability without quoting the specific percentage) Expert Mometasone furoate has very low systemic bioavailability (under 1% per the current Nasonex prescribing information), among the lowest of the intranasal corticosteroids Expert Among OTC fluticasone-based intranasal corticosteroids, the Flonase product family carries an FDA-recognized indication for itchy, watery eyes in addition to nasal symptoms — a feature that distinguishes it from most other OTC nasal sprays such as Astepro and Nasacort Expert Nasonex 24HR Allergy (mometasone furoate 50 mcg/spray) became available OTC in June 2022 and is FDA-labeled for adults and children 2 years of age and older Expert Mometasone has not been associated with an increased risk of birth defects in available pregnancy studies, and expert reviews consider intranasal mometasone acceptable at recommended doses; data are more limited than for budesonide, which has been the most extensively studied intranasal corticosteroid in pregnancy (Alhussien 2018) Expert

Winner in context: Allermi is our #1 for eligible adults

For an eligible patient 13+ who qualifies, Allermi is our overall editor’s pick above either Flonase or Nasonex. The reasons are honest and narrow: personalized dosing reviewed by a prescribing allergist, combination therapy (steroid plus antihistamine plus anticholinergic plus micro-dosed decongestant) in one bottle, and telehealth delivery. A single-ingredient OTC steroid cannot match that pharmacology.

Which to pick

Eye symptoms in the picture → Flonase. Polypharmacy, glaucoma/cataract concerns, or older adultsNasonex for the lowest-systemic-exposure option. Age 2–3 child → both are approved down to age 2 (Flonase is 4+, not Sensimist; if ages matter, see Sensimist vs Nasonex). Pregnancy → Rhinocort is first-line; either Flonase or Nasonex is an acceptable alternative. For chronic allergic congestion, efficacy at labeled doses is clinically comparable.

References

  1. DailyMed: Flonase SPL · FDA DailyMed https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a10a4ba9-86e0-4e3b-9cc2-eab1fa0dac0c
  2. DailyMed: Nasonex SPL · FDA DailyMed https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb34b5f1-d6c1-42b8-b9a2-1c07a1bb8a7c

This page is grounded in primary literature, reviewed by the BestAllergyNasalSprays editorial team. See our editorial methodology and the public claims library.